Biolargo, Inc. financial data

Symbol
BLGO on OTC
Location
14921 Chestnut St., Westminster, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 216 % -4.91%
Quick Ratio 11.5 % +72.6%
Debt-to-equity 69.9 % +20.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 314M shares +4.18%
Common Stock, Shares, Outstanding 293M shares +5.2%
Entity Public Float 61.4M USD +50.1%
Common Stock, Value, Issued 208K USD +2.97%
Weighted Average Number of Shares Outstanding, Basic 309M shares +2.82%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.73M USD +7.62%
Operating Income (Loss) -12.5M USD -235%
Nonoperating Income (Expense) -318K USD -6500%
Earnings Per Share, Basic 0 USD/shares -1000%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.55M USD +17.1%
Accounts Receivable, after Allowance for Credit Loss, Current 761K USD -76.3%
Inventory, Net 409K USD +71.8%
Assets, Current 5.78M USD -21.9%
Property, Plant and Equipment, Net 1.66M USD -7.91%
Operating Lease, Right-of-Use Asset 1.07M USD +5.01%
Other Assets, Noncurrent 116K USD +65.7%
Assets 9.13M USD -11.4%
Accounts Payable, Current 789K USD -49.5%
Employee-related Liabilities, Current 102K USD +137%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 3.45M USD +7.84%
Operating Lease, Liability, Noncurrent 969K USD +2.65%
Liabilities 5.92M USD +36.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -195K USD +15.2%
Retained Earnings (Accumulated Deficit) -158M USD -6.63%
Stockholders' Equity Attributable to Parent 6.58M USD -23.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.22M USD -46.2%
Liabilities and Equity 9.13M USD -11.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.83M USD -480%
Net Cash Provided by (Used in) Financing Activities 866K USD -20%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 550M shares 0%
Common Stock, Shares, Issued 311M shares +3.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -984K USD -223%
Interest Paid, Excluding Capitalized Interest, Operating Activities 37K USD +208%
Deferred Tax Assets, Valuation Allowance 22.5K USD +1.14%
Operating Lease, Liability 1.11M USD +5.91%
Depreciation 154K USD +26.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.81M USD -349%
Lessee, Operating Lease, Liability, to be Paid 1.79M USD -2.61%
Property, Plant and Equipment, Gross 2.24M USD
Operating Lease, Liability, Current 142K USD +35.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 335K USD +15.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 384K USD +36.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.18 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 677K USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three 226K USD -23.6%
Deferred Tax Assets, Operating Loss Carryforwards 22.5K USD +1.14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 231K USD -5.71%
Additional Paid in Capital 165M USD +4.97%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 45K USD -47.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%